Home › Companies › APELLIS PHARMACEUTICALS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and APELLIS PHARMACEUTICALS INC.’s Form 8-K, filed June 4, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 3, 2025: 5 items on APELLIS PHARMACEUTICALS INC.’s Form 8-K, filed June 4, 2025: 2 approved · 3 passed (calculated).
Significant dissent: 2 directors (32.5%, 22.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Explore APELLIS PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are APELLIS PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: A. Sinclair Dunlop | 54,091,088 | -- | -- | 26,037,795 | 23,918,223 | 68% | Passed (calculated) | — |
| Elect Director: Alec Machiels | 62,314,110 | -- | -- | 17,814,774 | 23,918,223 | 78% | Passed (calculated) | — |
| Elect Director: Keli Walbert | 76,951,740 | -- | -- | 3,177,144 | 23,918,223 | 96% | Passed (calculated) | — |
| The stockholders of the Company ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. | 103,876,326 | 54,603 | 116,178 | -- | -- | 99.9% | Approved | — |
| The stockholders of the Company approved the advisory vote on the compensation of the Company's named executive officers. | 75,901,920 | 4,167,103 | 59,860 | -- | 23,918,223 | 95% | Approved | — |
Source: APELLIS PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 4, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
256 asset managers disclosed a vote on at least one APELLIS PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of APELLIS PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: A. Sinclair Dunlop
APELLIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: A. Sinclair Dunlop”): 54,091,088 for, 26,037,795 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 28,665,899 for, 4,059,757 withheld, 4 abstained, 740 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,436,530 | 0 | 4 | 1,465 | For |
| Fidelity | 2,671,946 | 0 | 0 | 0 | For |
| State Street | 5,240 | 0 | 0 | 2,161,662 | Withhold |
| BlackRock | 2,038,646 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,113,791 | 0 | 0 | 0 | For |
| Charles Schwab | 962,525 | 0 | 0 | 0 | For |
| TIAA | 482,718 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 460,713 | Withhold |
| Columbia Threadneedle | 403,939 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 0 | 287,765 | Withhold |
| Hartford | 237,706 | 0 | 0 | 0 | For |
| Victory Capital | 1,022 | 0 | 0 | 198,778 | Withhold |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 138,505 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 104,202 | Withhold |
| Jackson National | 0 | 0 | 0 | 82,733 | Withhold |
| Northwestern Mutual | 55,533 | 0 | 0 | 24,155 | Mixed |
| MASTER INVESTMENT PORTFOLIO | 74,050 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 71,139 | Withhold |
| SEI | 0 | 0 | 0 | 66,937 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 62,474 | Withhold |
| Waddell & Reed | 0 | 0 | 0 | 55,497 | Withhold |
| Voya | 0 | 0 | 0 | 45,911 | Withhold |
| JPMorgan | 39,821 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 39,528 | Withhold |
| DWS | 0 | 0 | 0 | 34,127 | Withhold |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: Alec Machiels
APELLIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Alec Machiels”): 62,314,110 for, 17,814,774 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 29,574,063 for, 3,151,594 withheld, 2 abstained, 740 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,437,996 | 0 | 2 | 0 | For |
| Fidelity | 1,741,924 | 0 | 0 | 930,022 | Mixed |
| State Street | 2,166,817 | 0 | 0 | 85 | For |
| BlackRock | 0 | 0 | 0 | 2,038,646 | Withhold |
| Prudential/PGIM | 1,113,791 | 0 | 0 | 0 | For |
| Charles Schwab | 962,525 | 0 | 0 | 0 | For |
| TIAA | 482,718 | 0 | 0 | 0 | For |
| Invesco | 460,713 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 403,939 | 0 | 0 | 0 | For |
| AQR | 287,765 | 0 | 0 | 0 | For |
| Hartford | 237,706 | 0 | 0 | 0 | For |
| Victory Capital | 199,800 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 138,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 104,202 | 0 | 0 | 0 | For |
| Jackson National | 82,733 | 0 | 0 | 0 | For |
| Northwestern Mutual | 79,688 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 74,050 | Withhold |
| First Trust | 71,139 | 0 | 0 | 0 | For |
| SEI | 65,670 | 0 | 0 | 1,267 | For |
| Direxion Shares ETF Trust | 62,474 | 0 | 0 | 0 | For |
| Waddell & Reed | 55,497 | 0 | 0 | 0 | For |
| Voya | 45,911 | 0 | 0 | 0 | For |
| JPMorgan | 39,821 | 0 | 0 | 0 | For |
| ProShares | 39,528 | 0 | 0 | 0 | For |
| DWS | 34,127 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders: Keli Walbert
APELLIS PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Keli Walbert”): 76,951,740 for, 3,177,144 withheld, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 32,517,454 for, 208,205 withheld, 1 abstained, 740 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,436,533 | 0 | 1 | 1,465 | For |
| Fidelity | 2,671,946 | 0 | 0 | 0 | For |
| State Street | 2,166,902 | 0 | 0 | 0 | For |
| BlackRock | 2,038,646 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,113,791 | 0 | 0 | 0 | For |
| Charles Schwab | 962,525 | 0 | 0 | 0 | For |
| TIAA | 482,718 | 0 | 0 | 0 | For |
| Invesco | 460,713 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 403,939 | 0 | 0 | 0 | For |
| AQR | 287,765 | 0 | 0 | 0 | For |
| Hartford | 237,706 | 0 | 0 | 0 | For |
| Victory Capital | 199,800 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 138,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 104,202 | Withhold |
| Jackson National | 82,733 | 0 | 0 | 0 | For |
| Northwestern Mutual | 79,688 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 74,050 | 0 | 0 | 0 | For |
| First Trust | 71,139 | 0 | 0 | 0 | For |
| SEI | 65,670 | 0 | 0 | 1,267 | For |
| Direxion Shares ETF Trust | 62,474 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 0 | 0 | 55,497 | Withhold |
| Voya | 45,911 | 0 | 0 | 0 | For |
| JPMorgan | 39,821 | 0 | 0 | 0 | For |
| ProShares | 39,528 | 0 | 0 | 0 | For |
| DWS | 34,127 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 89.9% for (June 5, 2024 meeting) ▲ 4.9 pts
Description as filed by funds: TO HOLD AN ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
APELLIS PHARMACEUTICALS INC.’s own tally for this item (“The stockholders of the Company approved the advisory vote on the compensation of the Company's named executive officers.”): 75,901,920 for, 4,167,103 against — passed, per its Form 8-K filed June 4, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(c) The stockholders of the Company approved the advisory vote on the compensation of the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,435,161 | 2,837 | 0 | 0 | For |
| Fidelity | 2,671,946 | 0 | 0 | 0 | For |
| State Street | 2,164,346 | 2,556 | 0 | 0 | For |
| BlackRock | 2,038,646 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,113,791 | 0 | 0 | 0 | For |
| Charles Schwab | 962,525 | 0 | 0 | 0 | For |
| TIAA | 0 | 482,718 | 0 | 0 | Against |
| Invesco | 460,713 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 403,939 | 0 | 0 | 0 | For |
| AQR | 287,765 | 0 | 0 | 0 | For |
| Hartford | 237,706 | 0 | 0 | 0 | For |
| Victory Capital | 199,800 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 138,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 104,202 | 0 | 0 | 0 | For |
| Jackson National | 82,733 | 0 | 0 | 0 | For |
| Northwestern Mutual | 79,688 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 74,050 | 0 | 0 | 0 | For |
| First Trust | 71,139 | 0 | 0 | 0 | For |
| SEI | 65,670 | 1,267 | 0 | 0 | For |
| Direxion Shares ETF Trust | 62,474 | 0 | 0 | 0 | For |
| Waddell & Reed | 55,497 | 0 | 0 | 0 | For |
| Voya | 45,911 | 0 | 0 | 0 | For |
| JPMorgan | 39,821 | 0 | 0 | 0 | For |
| ProShares | 39,528 | 0 | 0 | 0 | For |
| DWS | 34,127 | 0 | 0 | 0 | For |
Fund voting reports, all 60 managers: 32,230,743 for, 494,181 against, 735 abstained, 740 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 11,895,808 | 0 | 0 | 0 | For |
| Wellington | 11,883,343 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 4,944,546 | 0 | 0 | 0 | For |
| State Street | 3,618,060 | 4,126 | 0 | 0 | For |
| BlackRock | 3,170,007 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,237,511 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 2,061,846 | 4,298 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,955,202 | 0 | 0 | 0 | For |
| AQR | 1,881,555 | 0 | 0 | 0 | For |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 0 | 1,835,131 | 0 | 0 | Against |
| Deep Track Capital, LP | 1,503,630 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,432,300 | 0 | 0 | 0 | For |
| Fidelity | 1,398,299 | 0 | 0 | 0 | For |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,050,700 | 0 | 0 | 0 | For |
| Charles Schwab | 967,735 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 916,864 | 0 | 0 | 0 | For |
| Amundi | 0 | 592,918 | 0 | 0 | Against |
| Invesco | 517,298 | 0 | 0 | 0 | For |
| Nuveen | 0 | 491,498 | 0 | 0 | Against |
| Northern Trust | 481,423 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 318,396 | 0 | 0 | 0 | For |
| Man Group plc | 310,283 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 305,258 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 292,198 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 250,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 212 managers: 57,307,415 for, 3,500,933 against, 36,338 abstained, 9,627 not voted, 53,975 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
97% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; and
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Hartford | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Northwestern Mutual | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| First Trust | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| Waddell & Reed | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| DWS | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 59 managers: 735 abstained, 740 not voted, 32,720,213 1 year, 1,571 3 year, 1 unknown, 0 2 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Wellington | 0 | 0 | 0 | 0 | -- |
| Avoro Capital Advisors LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| JENNISON ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| CANADA PENSION PLAN INVESTMENT BOARD | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | -- |
| Amundi | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Camber Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 203 managers: 96,909 for, 2,549 against, 9,627 not voted, 48,371,530 1 year, 142,947 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (June 5, 2024 meeting) unchanged
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
APELLIS PHARMACEUTICALS INC.’s own tally for this item (“The stockholders of the Company ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 103,876,326 for, 54,603 against — passed, per its Form 8-K filed June 4, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(b) The stockholders of the Company ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 32,723,901 for, 1,023 against, 735 abstained, 740 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,437,998 | 0 | 0 | 0 | For |
| Fidelity | 2,671,946 | 0 | 0 | 0 | For |
| State Street | 2,166,902 | 0 | 0 | 0 | For |
| BlackRock | 2,038,646 | 0 | 0 | 0 | For |
| Prudential/PGIM | 1,113,791 | 0 | 0 | 0 | For |
| Charles Schwab | 962,525 | 0 | 0 | 0 | For |
| TIAA | 482,718 | 0 | 0 | 0 | For |
| Invesco | 460,713 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 403,939 | 0 | 0 | 0 | For |
| AQR | 287,765 | 0 | 0 | 0 | For |
| Hartford | 237,706 | 0 | 0 | 0 | For |
| Victory Capital | 199,800 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 138,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 104,202 | 0 | 0 | 0 | For |
| Jackson National | 82,733 | 0 | 0 | 0 | For |
| Northwestern Mutual | 79,688 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 74,050 | 0 | 0 | 0 | For |
| First Trust | 71,139 | 0 | 0 | 0 | For |
| SEI | 66,937 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 62,474 | 0 | 0 | 0 | For |
| Waddell & Reed | 55,497 | 0 | 0 | 0 | For |
| Voya | 45,911 | 0 | 0 | 0 | For |
| JPMorgan | 39,821 | 0 | 0 | 0 | For |
| ProShares | 39,528 | 0 | 0 | 0 | For |
| DWS | 34,127 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. All 60 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 125,661,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 16.26% |
| 2 | Fidelity | 2.13% |
| 3 | State Street | 1.72% |
| 4 | BlackRock | 1.62% |
| 5 | Prudential/PGIM | 0.89% |
| 6 | Charles Schwab | 0.77% |
| 7 | TIAA | 0.38% |
| 8 | Invesco | 0.37% |
| 9 | Columbia Threadneedle | 0.32% |
| 10 | AQR | 0.23% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | EcoR1 Capital, LLC | 9.47% |
| 2 | Wellington | 9.46% |
| 3 | Avoro Capital Advisors LLC | 3.93% |
| 4 | State Street | 2.88% |
| 5 | BlackRock | 2.52% |
| 6 | Siren, L.L.C. | 1.78% |
| 7 | JENNISON ASSOCIATES LLC | 1.64% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.56% |
| 9 | AQR | 1.50% |
| 10 | SUVRETTA CAPITAL MANAGEMENT, LLC | 1.46% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Wellington Management | 12,303,252 | 9.79% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 10,130,356 | 8.06% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 9,626,123 | 7.66% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 6,329,598 | 5.04% | Form 13F, quarter ended March 31, 2025 |
| Deep Track Capital, LP | 4,532,374 | 3.61% | Schedule 13G, filed May 15, 2026 |
| State Street | 3,941,405 | 3.14% | Form 13F, quarter ended March 31, 2025 |
| RTW Investments, LP | 3,685,045 | 2.93% | Schedule 13G, filed May 15, 2026 |
| Geode Capital | 1,950,046 | 1.55% | Form 13F, quarter ended March 31, 2025 |
| FMR (Fidelity) | 1,503,209 | 1.20% | Form 13F, quarter ended March 31, 2025 |
| Norges Bank | 1,007,920 | 0.80% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 125,661,000 shares outstanding, as reported by APELLIS PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At APELLIS PHARMACEUTICALS INC.'s shareholder meeting held June 3, 2025, in the 2024-2025 proxy season, 256 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,139 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO HOLD AN ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. — APELLIS PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: APELLIS PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from APELLIS PHARMACEUTICALS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
APELLIS PHARMACEUTICALS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).
Proxy Votes Now, “APELLIS PHARMACEUTICALS INC. 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/apellis-pharmaceuticals-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.